We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by ...

A new way to deliver protective antibodies against COVID-19 was tested in a Phase I clinical trial. Instead of injecting ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced another successful readout for its ECD program, which is evaluating a blood-based screening test for the ...

Pure digital model companies, such as platforms (marketplaces, mobility apps) or SaaS. Companies that apply technology to a ...

A label-free nanopore platform uses programmable DNA circuits to build versatile molecular logic gates, forming a universal basis for scalable DNA computing and advanced biosensing applications.

With the number of reported shootings in London, Ont., reaching 20 in 2025, the police service says it's working tirelessly ...

A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a ...

When it comes to treating disease, one promising avenue is addressing the presence of senescent cells. These cells—also known ...

Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.

Human remains found in an abandoned home in Georgia nearly four years ago have been identified by Othram, a forensic laboratory, as Christopher Lamont Williams ...

From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...

To solve this critical challenge, he founded Nephrogen in 2022, a biotech startup that uses AI and advanced screening to ...